The Journey of Biopharmaceutical Innovation in Greece
Imagine a patient with a rare condition in Greece who waits for years to access a new therapy. This is not an exception: reimbursement of innovative treatments in Greece is slow and only a small proportion of new therapies is available. The human cost is real. Yet biopharmaceutical science is advancing rapidly: international authorities classify…